3月 2026
- 首頁
- Provention Bio
3月 2026Provention Bio的市場佔有率分析
Discover how Sanofi, a global pharmaceutical company, is shaping healthcare in the US with innovative solutions and treatments.
Provention Bio(包含公司地區)
查看更多網站流量與參與度資訊- proventionbio.com
Provention Bio截至 3月 2026 的總收入為 10M - 15M
Provention Bio 熱門網域產生的總收入
Provention Bio 熱門網域 3 年內的總收入
Provention Bio 熱門網域的總收入
Provention Bio的熱門網域總造訪量
了解Provention Bio市場觸達率與潛在市場影響力。
過去 3 個月的訪問總量
無可顯示數據
無可顯示數據
Provention Bio的熱門網域平均造訪時長
分析Provention Bio參與度指標。
過去 3 個月平均造訪時長
無可顯示數據
無可顯示數據
Provention Bio的熱門網域平均頁面瀏覽量
了解Provention Bio如何保持使用者的參與度、培養其興趣,並鼓勵他們採取下一步。
過去 3 個月平均頁面瀏覽量
無可顯示數據
無可顯示數據
想要取得更深入的流量洞見?
篩選超過 2,030 萬家線上企業。在流量激增、開始或停止使用技術或獲得正面評價時,發現新的潛在客戶。
新聞與訊號來自Provention Bio
透過 Similarweb 銷售訊號提醒,每當目標受眾出現新的機會或威脅時,你就會收到每日更新的已識別購買訊號。
新聞Eacademy Sanofi acquires Provention Bio Inc. for $2.9B.The same day, Sanofi acquired Provention Bio for $2.9 billion to enhance its diabetes medicine portfolio.
7月 1, 2023閱讀更多
新聞Sanofi acquired Provention Bio Inc. for $2.9B on Mar 20th '23.Paris, France – April 10, 2023 – Sanofi announced today that it has withdrawn and refiled its Premerger Notification and Report Form under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act”), in connection with Sanofi's pending acquisition of Provention Bio, Inc.
4月 4, 2023閱讀更多
新聞Provention Bio Inc. had issues with possible breaches of fiduciary duty and other violations of law on Mar 13th '23.MILWAUKEE, March 13, 2023 /PRNewswire/ -- Ademi LLP is investigating Provention Bio (Nasdaq: PRVB) for possible breaches of fiduciary duty and other violations of law in its transaction with Sanofi.
3月 13, 2023閱讀更多
查看所有Provention Bio信號
讓銷售團隊專注於最有希望的機會。透過安排機會的優先順序,並在正確的時間參與,您可將工作最佳化,並完成更多交易。
